Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Power Plate Int LtdfiledCriticalPower Plate Int Ltd
Priority to ECSP088337priorityCriticalpatent/ECSP088337A/en
Publication of ECSP088337ApublicationCriticalpatent/ECSP088337A/en
La presente invención se refiere a una máquina de acondicionamiento físico (1) para entrenar un cuerpo que comprende un armazón (2) con un elemento de vibración (3), un generador de vibración (4) acoplado de manera operativa al elemento de vibración (3). El elemento de vibración (3) está soportado por un armazón base de absorción de vibración (9). Regular el nivel de absorción del armazón base de absorción de vibración (9) permite fijar la absorción de vibración de tal manera que las vibraciones del elemento de vibración (3) sean amortiguadas al grado seleccionado, como resultado una carga de entrenamiento deseada por el usuario es obtenida.The present invention relates to a physical conditioning machine (1) for training a body comprising a frame (2) with a vibration element (3), a vibration generator (4) operatively coupled to the vibration element ( 3). The vibration element (3) is supported by a vibration absorption base frame (9). Adjusting the absorption level of the vibration absorption base frame (9) allows the vibration absorption to be set in such a way that the vibrations of the vibration element (3) are damped to the selected degree, as a result a training load desired by the user It is obtained.
ECSP0883372008-04-022008-04-02
PHYSICAL CONDITIONING MACHINE THAT HAS A VIBRATION ABSORPTION SUPPORT
ECSP088337A
(en)
Compounds derived from arylsulfonamides, modulators of ccr3 receptor activity; pharmaceutical composition comprising them; Useful in the treatment of an inflammatory disease such as asthma, allergic rhinitis, atopic dermatitis, epoc among others.
Compounds derived from 1- (2-alkyl-2,3-dihydro-benzofuran-4-yl) -pyrrolidin-3-ylaminoacyl; pharmaceutical composition; and its use for the treatment or prevention of melatoninergic disorders such as depression, stress, sleep disorders, insomnia, diabetes, Parkinson's disease, Alzheimer's disease, among others.
Arrangement for damping vibration of a fiber web machine equipment assembly and method for damping vibration with a fiber web machine equipment assembly
4- [2,3-Difluoro-6- (2-fluoro-4-methyl-phenyl-sulfanyl) -piperidine; pharmaceutical composition comprising said compound; and its use in the treatment of CNS disorders such as major depressive disorder, treatment-resistant depression, Alzheimer's disease, Parkinson's disease, multiple sclerosis, among others.